The company expects to benefit from growing appetite to reduce nicotine levels and ban menthol. Read More
Tags : 22nd Century Group
The money will help fund the anticipated growth of its VLN and GVB business lines. Read More
The company's low-nicotine leaf complies with the country's new limits.Read More
RXP’s products include CBD isolate and numerous variations of finished products.Read More
22nd Century partnered with Cannabinoid API Solutions and Transo-Pharm. Read More
The deal makes possible the launch of VLN in virtually every targeted U.S. market. Read More
The proposed measure could leave VLN as the only menthol cigarette in the U.S.Read More
The industry veteran has 35-plus years of experience in tobacco and packaged-goods. Read More
The center will speed up transaction flow and optimize customs treatment.Read More
The company continues to roll out its VLN reduced-nicotine cigarette in the United States. Read More
